4-(4-Methylpiperazin-1-yl)aniline → [8-(2-Methoxy-5-trifloromethylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine

HRID 472541Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 472541
Cl[C:2]1[N:22]=[C:5]2[C:6]([C:10]3[CH:15]=[C:14]([C:16]([F:19])([F:18])[F:17])[CH:13]=[CH:12][C:11]=3[O:20][CH3:21])=[CH:7][CH:8]=[CH:9][N:4]2[N:3]=1.[CH3:23][N:24]1[CH2:29][CH2:28][N:27]([C:30]2[CH:35]=[CH:34][C:33]([NH2:36])=[CH:32][CH:31]=2)[CH2:26][CH2:25]1>>[CH3:21][O:20][C:11]1[CH:12]=[CH:13][C:14]([C:16]([F:19])([F:18])[F:17])=[CH:15][C:10]=1[C:6]1[C:5]2[N:4]([N:3]=[C:2]([NH:36][C:33]3[CH:32]=[CH:31][C:30]([N:27]4[CH2:26][CH2:25][N:24]([CH3:23])[CH2:29][CH2:28]4)=[CH:35][CH:34]=3)[N:22]=2)[CH:9]=[CH:8][CH:7]=1

Komponenten

3

Edukt 2

HCID 7372534-(4-Methylpiperazin-1-yl)anilineHCID 674789492-Chloro-8-(2-methoxy-5-trifluoromethyl-phenyl)-[1,2,4]triazolo[1,5-a]pyridine

Produkt 1

HCID 49839133[8-(2-Methoxy-5-trifloromethylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine

Versuchsvorschrift

[8-(2-methoxy-5-trifloromethylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine was prepared from 2-chloro-8-(2-methoxy-5-trifluoromethyl-phenyl)-[1,2,4]triazolo[1,5-a]pyridine (0.150 g, 0.5 mmol), and 4-(4-methylpiperazin-1-yl)phenylamine (0.096 g, 0.5 mmol) in a manner analogous to Example 2d. Product was isolated as a foam (0.1 g, 40%). 1H NMR (400 MHz, CDCl3, δ, ppm): 8.43 (d, J=7.6 Hz, 1H), 7.94 (s, 1H), 7.68 (d, J=8.2 Hz, 1H), 7.53 (d, J=7.1 Hz, 1H), 7.48 (d, J=7.1 Hz, 2H), 7.12 (d. J=8.2 Hz, 1H), 6.99-6.90 (m, 3H), 6.67 (s, 1H), 3.88 (s, 3H), 3.21-3.11 (m, 4H), 3.06 (s, 3H), 2.65-2.55 (m, 4H). MS=483 (MH)+.

Quellen und Nachweise

ORD-Eintrag
ord-c8daf82454a043cda1335381e010eb1d
Quelldatensatz
uspto-grants-2014_01
Patentnummer
US08633173B2

Notizen zur Reaktion

Wird geladen…